Evidence map›Paper›PMID 23625206›Full record

ArticleMolecular and cellular biochemistry2013

Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.

R L Babu, M Naveen Kumar, Rajeshwari H Patil, K S Devaraju, Govindarajan T Ramesh, S Chidananda Sharma

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. PARP-1 as a novel target in endocrine-resistant breast cancer.Journal of experimental & clinical cancer research : CR · 2025
    Article
  4. Article
  5. Review
  6. Role of Fra-2 in cancer.Cell death and differentiation · 2024
    Review
  7. Article
  8. Synergistic Cytotoxicity betweenEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

R L BabuDepartment of Microbiology and Biotechnology, Bangalore University, Bangalore, 560 056 Karnataka, India.
M Naveen Kumar
Rajeshwari H Patil
K S Devaraju
Govindarajan T Ramesh
S Chidananda Sharma
Bangalore University · INNorfolk State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The activated transcription factor ERα plays an important role in the breast development and progression of cancer. In a non-classical pathway ER interacts with other transcription factors AP-1, NFkB, SP1, etc. AP-1 transcription factors control rapid responses of mammalian cells to stimuli that impact proliferation, differentiation, and transformation. AP-1 factors are leucine zipper proteins belonging to members of the Jun family (c-Jun, JunB, and JunD) and Fos family (c-Fos, FosB, Fra-1, and Fra-2) proteins. Although AP-1 factors are well characterized, not much is known about the expression pattern of the AP-1 factors in breast cancer cells. Hence to determine which AP-1 factors are expressed and regulated by estrogen, we used human breast cancer MCF-7 cells as in vitro model system. The MCF-7 cells were treated with or without estradiol-17β (E2) or antiestrogen tamoxifen (TMX) and the cell proliferation and viability was assessed by MTT assay. The expression of different AP-1 factors was analyzed by semi-quantitative RT-PCR. The cells treated with E2 found to increase the cell proliferation by more than 35 % and TMX an antiestrogen decreased by 29 % compared to control. The E2 found to induce the expression of c-Jun, Fra-1, and c-Fos, while TMX decreased the expression. In addition TMX also decreased the mRNA levels of Jun-D and Fra-2. These results suggest that the AP-1 factors c-Jun, c-Fos, and Fra-1 may be involved in the proliferation and transformation of MCF-7 cells. E2 also found to induce cyclin D1 and cyclin E1 mRNA transcripts of cell cycle regulators while TMX significantly decreased compared to control. Further E2 induced the anti-apoptotic Bcl-2 and TMX decreased mRNA transcripts. The data presented here support the E2-ERα-mediated MCF-7 cell proliferation and confirms the role of AP-1 factors in cell cycle regulation.

Indexed as

Basic-Leucine Zipper Transcription FactorsCell CycleCell Line, TumorCell ProliferationCell SurvivalCyclin D1Cyclin EDose-Response Relationship, DrugEstrogen AntagonistsEstrogensFos-Related Antigen 1Gene Expression Regulation, NeoplasticHumansMCF-7 CellsOncogene ProteinsProto-Oncogene Proteins c-bcl-2Basic-Leucine Zipper Transcription FactorsCCNE1 protein, humanCyclin D1Cyclin EEstrogen AntagonistsEstrogensFos-Related Antigen 1Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junReceptors, EstrogenTamoxifenTranscription Factor AP-1

Identifiers

PMID23625206
OpenAlexW2012890891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.